HLB Life Science Co. Ltd (067630) — Cash Flow Reinvestment Rate
HLB Life Science Co. Ltd (067630) has a Cash Flow Reinvestment Rate of 2.19x as of March 2023, reinvesting ₩7.79 Billion (capex ₩3.52 Billion plus investments ₩-4.27 Billion) from operating cash flow of ₩3.55 Billion. Check how high is HLB Life Science Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HLB Life Science Co. Ltd Cash Flow Reinvestment Rate (2012–2020)
Historical reinvestment intensity for HLB Life Science Co. Ltd across 4 annual periods. Explore how much of HLB Life Science Co. Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for HLB Life Science Co. Ltd (2012–2020)
Year-by-year capital reinvestment analysis for HLB Life Science Co. Ltd. For live market cap and broader valuation context, see how much is HLB Life Science Co. Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 12.05x | ₩24.21 Billion | ₩2.01 Billion | ₩8.41 Billion | ▲ +9080.6% |
| 2014 | 0.13x | ₩1.37 Billion | ₩10.43 Billion | ₩236.21 Million | ▲ +651.5% |
| 2013 | 0.02x | ₩51.48 Million | ₩2.95 Billion | ₩51.48 Million | ▼ -97.3% |
| 2012 | 0.66x | ₩9.18 Billion | ₩13.97 Billion | ₩9.18 Billion | — |